paclitaxel

This page shows the latest paclitaxel news and features for those working in and with pharma, biotech and healthcare.

MSD wins key EU approval for Keytruda, Alimta combo

The US regulator says it will take another three months for it to rule on Tecentriq in combination with Avastin, carboplatin and paclitaxel in the same frontline setting for metastatic

Latest news

Immuno-oncology at ASCO: survival data, combinations and new indications

On the agenda are overall survival data from the IMpower150 study of Tecentriq plus Avastin (bevacizumab) and chemotherapy (carboplatin and paclitaxel) in people with previously-untreated, non-squamous NSCLC, as well
Roche eyes September FDA verdict for triple NSCLC therapy

The submission is based on the IMpower150 study, which combined Tecentriq with Avastin (bevacizumab) and the standard first-line NSCLC chemotherapy regimen paclitaxel/carboplatin and doubled the 12-month progression-free ... of carboplatin and
Another Tecentriq win for Roche as Avastin combo boosts survival

The 1, 200 patient trial compared PD-L1 inhibitor Tecentriq with VEGF inhibitor Avastin as a combination as well as each drug individually on top of carboplatin and paclitaxel chemotherapy.
New data could put Roche’s Tecentriq first in squamous lung cancer

The phase III IMpower131 study showed that adding the PD-L1 inhibitor to standard first-line chemotherapy with carboplatin and Celgene’s Abraxane (nab-paclitaxel) in patients with advanced squamous ... the IMpower150 study which compared Tecentriq plus
MSD's Keytruda wins new bladder cancer indication in Europe

on investigator-choice chemotherapy (paclitaxel, docetaxel, vinflumime).

More from news
Approximately 10 fully matching, plus 108 partially matching documents found.

Latest Intelligence

Pharma deals in May 2015

Sorrento (Igdrasol)/ NantPharma. Asset acquisition. Acquisition of Igdrasol including Cynviloq (paclitaxel nanoparticle).
The rise of chronic disease in BRIC markets

For late-stage patients, Brazil physicians are more likely to use an anthracycline-based regimen without a taxane in the first line, gemcitabine, paclitaxel or a combination of both in the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

BMS appoints oncology development head

Dr Namouni first joined Bristol-Myers Squibb in France in 1999 as a life-cycle manager for chemotherapy drug Taxol (paclitaxel) and has since held a number of increasingly senior positions

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Director – Medical Education: Neg

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Manager- 4 days per week or full-time: Salary TBC

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Manager: Negotiable

Senior Account Manager – Healthcare Advertising: Salary TBC

Systematic Review Lead- London: Negotiable

Senior Medical Writer: Salary is DOE

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Healthcare PR Senior Account Manager: Salary TBC

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Training Manager - Surrey: Competitive Salary &Bonus

Sudler London - Senior Medical Writer: Competitive

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Subscribe to our email news alerts

PMHub

Add my company

Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....